Drugs / Oral N-acetycystein (NAC)
Oral N-acetycystein (NAC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00205647 | Jan 1997 → Mar 2000 | chronic bronchitis | Wake Forest University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral N-acetycystein (NAC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00205647 ↗ |
| Known as | N-acetycystein | “Oral N-acetycystein (NAC)” NCT00205647 ↗ |
| Known as | N-acetyl L-cysteine | “three different doses of N-acetyl L-cysteine (NAC) and placebo” NCT00205647 ↗ |
| Known as | NAC | “three different doses of N-acetyl L-cysteine (NAC) and placebo” NCT00205647 ↗ |
| Route | Oral | “Oral N-acetycystein (NAC)” NCT00205647 ↗ |